Back grey_arrow_rt.gif
 
Archived NATAP Articles from September 2002
 
null.gif
 
 
  1. Atazanavir Early Access Program - (9/30/02)

    2.  
  2. ICAAC - NEAT Study: new formulation of amprenavir - (9/30/02)

    3.  
  3. ICAAC - FTC+Efavirenz+ddI EC Once Daily; Tenofovir & mitochondrial DNA - (9/30/02)

    4.  
  4. ICAAC - Substitution of Efavirenz or Nevirapine for Protease Inhibitor (80% "success") - (9/30/02)

    5.  
  5. ICAAC - Kaletra: 4 year follow-up - (9/30/02)

    6.  
  6. ICAAC - Atazanavir: The Story Unfolds with Effectiveness Comparable To Efavirenz - (9/30/02)

    7.  
  7. ICAAC - Hepatitis ICAAC Report 1: identifying unknown routes for HCV transmission - (9/30/02)

    8.  
  8. ICAAC - 3TC Once Daily: equivalent to 3TC twice daily - (9/30/02)

    9.  
  9. ICAAC - 42nd ICAAC - New Entry Inhibitors In Early Development - (9/27/02)

    10.  
  10. ICAAC - 42nd ICAAC - New Discovery in HIV - (9/27/02)

    11.  
  11. Pegasys + Ribavirin: study results published - (9/27/02)

    12.  
  12. Effect of protease inhibitors on bone - Special report by Donald P. Kotler, MD, St Luke's-Roosevelt Medical Center, New York City - (9/26/02)

    13.  
  13. lipoWorkshop - HCV Viral Load Increases on HAART But CD4 Increase from HAART is Not Blunted: implications for when to begin HIV & HCV therapy - (9/26/02)

    14.  
  14. lipoWorkshop - HIV/Hepatitis & Insulin/Diabetes - (9/26/02)

    15.  
  15. lipoWorkshop - Body Composition Changes Observed in ACTG 384 - (9/26/02)

    16.  
  16. lipoWorkshop - Treating Diarrhea in HIV - (9/25/02)

    17.  
  17. lipoWorkshop - 36-week Safety and Tolerability Study of Extended-Release Niacin (ERN) for the Treatment of Elevated Triglycerides in HIV - (9/25/02)

    18.  
  18. lipoWorkshop - Nukes, Fat Loss, Mitochondrial Toxicity, Lactate - discussed below - (9/25/02)

    19.  
  19. lipoWorkshop - Switch Study From Nelfinavir to Atazanavir - (9/24/02)

    20.  
  20. HEPATITIS B PRIMER - (9/24/02)

    21.  
  21. lipoWorkshop - Atazanavir: preliminary week 24 study results show no increase in glucose, cholesterol and triglycerides - (9/24/02)

    22.  
  22. lipoWorkshop - LIPODYSTROPHY WORKSHOP day 1 - (9/23/02)

    23.  
  23. FDA Approves Adefovir for Chronic Hepatitis B - (9/23/02)

    24.  
  24. OSTEOPENIA IN HIV: tests and markers to evaluate bone loss - (9/23/02)

    25.  
  25. HIV Infection Rate Is Skyrocketing - (9/19/02)

    26.  
  26. The HIV Update - (9/19/02)

    27.  
  27. Viral load in HCV RNA-positive pregnant women - (9/18/02)

    28.  
  28. Hep C & Pregnancy: risks for transmission - (9/18/02)

    29.  
  29. Organ (Liver) Transplants - (9/18/02)

    30.  
  30. ROCHE ANNOUNCES SUBMISSION OF REQUEST TO FDA FOR APPROVAL OF T-20 - (9/18/02)

    31.  
  31. Roche's ribavirin Copegus available in all EU Countries within months - (9/18/02)

    32.  
  32. Does Patient Gender Affect Human Immunodeficiency Virus Levels? - (9/13/02)

    33.  
  33. Once-Daily HAART: Toward a New Treatment Paradigm - (9/13/02)

    34.  
  34. Cardiovascular Risk Associated With HIV Therapy: review by Judith Currier, MD - (9/13/02)

    35.  
  35. Does HAART harm the Liver? NNRTI-related or -unrelated hepatotoxicity? - (9/13/02)

    36.  
  36. Hepatitis Online Newsletter - (9/13/02)

    37.  
  37. Bananas May Beat Stroke Low-Potassium Diet Raises Stroke Risk - (9/13/02)

    38.  
  38. Alcohol and mitochondria: A dysfunctional relationship - (9/10/02)

    39.  
  39. Frequency of the HIV-protective CC chemokine receptor 5-32/32 genotype is increased in hepatitis C - (9/10/02)

    40.  
  40. Psychiatric disorders among veterans with hepatitis C infection - (9/10/02)

    41.  
  41. Interferon therapy prolonged life expectancy among chronic hepatitis C patients: for both responders & perhaps nonresponders - (9/10/02)

    42.  
  42. Low-Dose Prolonged Intermittent Interleukin-2 Adjuvant Therapy: Results of a Randomized Trial among Human Immunodeficiency Virus Positive Patients with Advanced Immune Impairment (<200 CD4s) - (9/09/02)

    43.  
  43. Serious Bradyarrhythmia That Was Possibly Induced by Lopinavir-Ritonavir in 2 Patients with Acquired Immunodeficiency Syndrome - (9/09/02)

    44.  
  44. HCV in HIV-Coinfection: ADAP, Access, Treatment Costs - (9/09/02)

    45.  
  45. Injection Drug Use Facilitates Hepatitis C Virus Infection of Peripheral Blood Mononuclear Cells - (9/09/02)

    46.  
  46. Researchers Document Rare Case of Second HIV Infection with Different Strain - (9/06/02)

    47.  
  47. Hepatitis C and Progression of HIV Disease - (9/06/02)

    48.  
  48. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection - (9/06/02)

    49.  
  49. Liver transplantation for patients on methadone maintenance - (9/06/02)

    50.  
  50. A Patient with HIV-1 Superinfection: safe sex, vaccine implications - (9/05/02)

    51.  
  51. Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol - (9/03/02)

    52.  
  52. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users - (9/03/02)

    53.  
  53. Virahep-c - (9/03/02)

    54.  
  54. HEPP (HIV & Hepatitis Education Prision Project) Subject: HCV and HCV in Prisions - Report Aug/Sept 2002 Vol. 5 Issue 8&9 - PDF Format - (9/03/02)

    55.